perindopril has been researched along with Recrudescence in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Kuker, W; Li, L; Rothwell, PM; Warlow, CP; Zuurbier, SM | 1 |
| Anderson, C; Arima, H; Bousser, MG; Chalmers, J; Harrap, S; Liu, L; MacMahon, S; Mancia, G; Neal, B; Omae, T; Tzourio, C; Woodward, M | 1 |
| Alexandre, J; Emile, G; Pujade-Lauraine, E | 1 |
| Halle, B; Munthe, S; Poulsen, FR; Søe, M | 1 |
| Bogachev, RS; Kober, DV; Kraĭtser, AP; Rfeenkova, VS | 1 |
| Cressman, AM; Fernandes, KA; Gomes, T; Juurlink, DN; Macdonald, EM; Mamdani, MM; Paterson, JM | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Godin, O; MacMahon, S; Mazoyer, B; Tzourio, C; Tzourio-Mazoyer, N | 1 |
| Batty, GD; Chalmers, J; Czernichow, S; Grobbee, DE; Huxley, R; Kengne, AP; Neal, B; Ninomiya, T; Woodward, M | 1 |
| Sillence, D; Tchan, M | 1 |
| Jacobsen, K | 1 |
| Davis, SM; Donnan, GA; Thrift, A | 1 |
| Bath, P | 1 |
| Berthet, K; Bousser, MG; Chalmers, JP; Colman, SA; MacMahon, SW; Neal, BC; Woodward, M | 1 |
| Campbell, DJ; Chalmers, J; Colman, S; Jenkins, AJ; Kemp, BE; Lowe, GD; MacMahon, SW; Neal, BC; Patel, A; Rumley, A; Woodward, M | 1 |
| Chiariello, M; Ferrari, R; Magrini, G; Nicolosi, GL; Remme, P; Tavazzi, L | 1 |
| Anderson, C; Arima, H; Bousser, MG; Butcher, K; Chalmers, J; Lees, KR; MacMahon, S; Omae, T; Reid, JL; Tzourio, C; Woodward, M | 1 |
| Shimada, K; Yoshimura, Y | 1 |
| Chalmers, J; MacMahon, S; Neal, B | 1 |
| Begley, F; Burke, T; Cahill, J; Kelly, J; Ledwidge, M; Maurer, B; McDonald, K; Quigley, P; Ryder, M; Timmons, L; Travers, B | 1 |
| Einecke, D | 1 |
| Masson, C | 1 |
3 review(s) available for perindopril and Recrudescence
| Article | Year |
|---|---|
The role of blood pressure lowering before and after stroke.
Topics: Aged; Antihypertensive Agents; Cerebral Infarction; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Placebos; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke Volume; Survival Analysis; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2005 |
[PROGRESS trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Humans; International Cooperation; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2006 |
10 trial(s) available for perindopril and Recrudescence
| Article | Year |
|---|---|
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Recurrence; Risk Factors; Stroke | 2014 |
Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Female; Hematoma, Subdural, Chronic; Humans; Male; Middle Aged; Neurosurgical Procedures; Perindopril; Prospective Studies; Recurrence; Retrospective Studies; Risk; Time Factors; Treatment Outcome | 2014 |
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Disorders; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Perindopril; Predictive Value of Tests; Recurrence; Stroke | 2009 |
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
Topics: Aged; Antihypertensive Agents; Body Weight; Cardiovascular Diseases; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Obesity; Overweight; Perindopril; Placebos; Proportional Hazards Models; Recurrence; Risk Reduction Behavior; Stroke | 2010 |
Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Comorbidity; Diabetes Complications; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Proportional Hazards Models; Recurrence; Risk; Risk Factors; Stroke; Treatment Outcome | 2004 |
Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Perindopril; Placebos; Recurrence; Risk; Risk Factors; Stroke | 2005 |
PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Perindopril; Recurrence | 1996 |
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Prognosis; Recurrence; Survival Rate; Treatment Outcome; World Health Organization | 1998 |
PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Recurrence; Stroke | 2000 |
Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzy
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Patient Care Team; Patient Discharge; Patient Readmission; Perindopril; Recurrence; Risk Factors; Survival Rate | 2001 |
10 other study(ies) available for perindopril and Recrudescence
| Article | Year |
|---|---|
Blood Pressure Control and Recurrent Stroke After Intracerebral Hemorrhage in 2002 to 2018 Versus 1981 to 1986: Population-Based Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; England; Female; Follow-Up Studies; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Middle Aged; Perindopril; Recurrence; Risk; Risk Factors; Stroke; Survival Analysis | 2021 |
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?
Topics: Amides; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cohort Studies; Disease-Free Survival; Drug Substitution; Enalapril; Female; Fumarates; Humans; Hypertension; Ovarian Neoplasms; Perindopril; Protein Kinase Inhibitors; Recurrence; Vascular Endothelial Growth Factor A | 2014 |
[Clinical aspects of vaso-and cardioprotection in patients with primary and recurrent myocardial infarction].
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Vessels; Drug Combinations; Endothelium-Dependent Relaxing Factors; Femoral Artery; Heart Failure; Humans; Indapamide; Male; Middle Aged; Myocardial Infarction; Perindopril; Recurrence; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Color; Vasoconstriction; Ventricular Remodeling | 2014 |
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Clopidogrel; Databases, Factual; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Lisinopril; Male; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Ramipril; Recurrence; Ticlopidine; Treatment Outcome | 2015 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
[The effect of Coversyl].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Perindopril; Recurrence; Stroke | 2002 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke; Treatment Outcome | 2003 |
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Coronary Disease; Female; Humans; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Risk Reduction Behavior; Stroke; Vascular Diseases | 2006 |
[PROGRESS Study examines transient cerebral ischemia and stroke patients. Future goal: attaining basic blood pressure control].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Humans; Indapamide; Ischemic Attack, Transient; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke | 2001 |
[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Recurrence; Risk; Risk Factors; Stroke; Time Factors | 2001 |